Trial Profile

A Phase 2 Clinical Trial of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in Participants with Major Depressive Disorder

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PRAX-114 (Primary)
Indications Major depressive disorder
Focus Adverse reactions; Pharmacokinetics; Proof of concept
Sponsors Praxis Precision Medicines

Most Recent Events

03 Mar 2022 Protocol was amended to add part C in the treatment arms.
03 Mar 2022 Status changed from recruiting to completed.
03 Nov 2021 According to a Praxis Precision Medicines media release, plans for the Phase 2b trial will be disclosed in the fourth quarter of 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com